je.st
news
British Medical Journal study into paroxetine, Aropax, reveals suicide risk
2015-09-17 03:38:24| Biotech - Topix.net
An ineffective depression drug was prescribed in the millions to children on the basis of flawed research that downplayed its risks of suicide and other serious events and overstated its benefits, a groundbreaking study has shown. An international team of researchers has obtained previously buried data from a now infamous trial of the antidepressant medication paroxetine, which is sold under the brand names Aropax here and Paxil overseas.
Tags: study
journal
medical
risk
Category:Biotechnology and Pharmaceuticals